retatrutidehow it workstriple agonistGLP-1

How Retatrutide Works: The Triple-Agonist Explained

How retatrutide works: the triple-agonist mechanism explained, and why it may outperform other GLP-1s for weight loss.

Peptul Team·September 8, 2026·3 min read
How Retatrutide Works: The Triple-Agonist Explained

How Retatrutide Works: The Triple-Agonist Explained

Retatrutide is posting the highest weight-loss numbers anyone has recorded for this class of drug. The reason comes down to how it works - it pulls one more lever than anything before it. Here is the mechanism in plain English.

The one-sentence version

Retatrutide mimics three natural hormones at once to cut appetite, slow digestion, and nudge your body to burn more energy.

That third one is the difference-maker. Here is the detail.

It is a "triple agonist"

Most weight-loss drugs hit one or two hormone targets. Retatrutide hits three:

  • GLP-1 - curbs appetite and slows digestion (the workhorse of this drug class)
  • GIP - a second appetite-and-metabolism hormone (tirzepatide adds this one too)
  • Glucagon - the new addition. Among other things, glucagon can increase energy expenditure - basically nudging your body to burn more.

GLP-1 and GIP are the same two targets as tirzepatide. The glucagon receptor is what makes retatrutide a "triple agonist" and is the leading theory for why it may outperform even tirzepatide. Compare them directly in Retatrutide vs Tirzepatide.

What that does in practice

The three targets combine into:

Less appetite and longer fullness - the GLP-1/GIP side, same as other drugs in the class.

More energy burned - the glucagon side, which is the extra lever the others do not have.

Eat less + feel full longer + burn a bit more = the biggest deficits seen in the class, which is why trial weight-loss numbers have been so high.

The honest caveat

Retatrutide is still investigational - not approved, still in trials (see Is Retatrutide Available Yet?). The glucagon mechanism is powerful but also why it is still being carefully studied. Impressive mechanism, but not a finished, approved product yet.

Quick FAQ

How does retatrutide work? It activates three hormone receptors (GLP-1, GIP, glucagon) to reduce appetite, slow digestion, and increase energy expenditure.

What makes it different from tirzepatide? Tirzepatide hits two targets (GLP-1, GIP); retatrutide adds a third (glucagon), which may drive more fat loss.

Why does the glucagon part matter? It can increase how much energy your body burns - the extra lever the other drugs do not pull.


This is educational info for research purposes, not medical advice. Retatrutide is investigational and not approved. Consult a healthcare professional.

Tags

retatrutidehow it workstriple agonistGLP-1

For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.